Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic

The WHO 2020 global TB Report estimates that in 2019 there were an estimated 500,000 cases of multi-drug resistant TB (MDR-TB) of which only 186,772 MDR-TB cases were diagnosed, and positive treatment outcomes were achieved in 57% of them. These data highlight the need for accelerating and improving...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiberi, Simon, Vjecha, Michael J., Zumla, Adam, Galvin, Jessica, Migliori, Giovanni Battista, Zumla, Alimuddin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944856/
https://www.ncbi.nlm.nih.gov/pubmed/33713815
http://dx.doi.org/10.1016/j.ijid.2021.02.067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944856/
https://www.ncbi.nlm.nih.gov/pubmed/33713815
http://dx.doi.org/10.1016/j.ijid.2021.02.067

Ejemplares similares